This Bull Market Indicator called NVDA at $116

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

TGTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,645,995.97

TG Therapeutics Insider Trading History Chart

TG Therapeutics Share Price & Price History

^$30.84

▼ -4.06 (-11.63%)

As of 11/14/2024 05:45 PM ET

Days: 30 | 90 | 365

Trump’s Back, but DC’s Coming for Your Money!

From Genesis Gold Group | Ad

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

TG Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2024	Sagar Lonial	Director	Sell	5,000	$30.44	$152,200.00	100,195
3/12/2024	Laurence N. Charney	Director	Sell	22,000	$15.97	$351,340.00	215,229
1/5/2024	Laurence N. Charney	Director	Sell	17,500	$19.03	$333,025.00	237,229
1/3/2024	Sean A. Power	CFO	Sell	47,867	$16.91	$809,430.97	606,969
8/11/2023	Michael S. Weiss	CEO	Buy	100,000	$10.13	$1,013,000.00	12,073,021
6/23/2023	Sagar Lonial	Director	Sell	34,854	$23.37	$814,537.98	93,878
6/2/2023	Sean A. Power	CFO	Sell	73,647	$26.70	$1,966,374.90	654,836
1/6/2023	Yann Echelard	Director	Buy	9,000	$10.64	$95,760.00	201,848
1/4/2023	Laurence N. Charney	Director	Sell	30,000	$11.10	$333,000.00	234,729
1/4/2022	Michael S. Weiss	CEO	Sell	37,549	$19.20	$720,940.80
1/4/2022	Sean A. Power	CFO	Sell	75,312	$19.20	$1,445,990.40

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for TG Therapeutics (NASDAQ:TGTX)

58.58% of TG Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

TG Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Verition Fund Management LLC	45,699	$1.07M	0.0%	-12.6%	0.029%
11/14/2024	Captrust Financial Advisors	30,327	$0.71M	0.0%	+21.1%	0.019%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	293,927	$6.88M	0.0%	-8.7%	0.189%
11/14/2024	Public Sector Pension Investment Board	283,000	$6.62M	0.0%	N/A	0.182%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	31,147	$0.73M	0.0%	+12.0%	0.020%
11/13/2024	BNP Paribas Financial Markets	117,985	$2.76M	0.0%	-17.3%	0.076%
11/13/2024	Advantage Alpha Capital Partners LP	22,379	$0.52M	0.1%	-34.2%	0.014%
11/13/2024	FMR LLC	1,184,158	$27.70M	0.0%	-2.6%	0.761%
11/13/2024	The Manufacturers Life Insurance Company	79,191	$1.85M	0.0%	-1.8%	0.051%
11/13/2024	Harvest Fund Management Co. Ltd	4,761	$0.11M	0.0%	N/A	0.003%
11/12/2024	Penserra Capital Management LLC	98,144	$2.30M	0.0%	+293.6%	0.063%
11/12/2024	Algert Global LLC	104,252	$2.44M	0.1%	-29.2%	0.067%
11/12/2024	Citigroup Inc.	168,277	$3.94M	0.0%	+125.7%	0.109%
11/12/2024	Eagle Asset Management Inc.	168,795	$3.95M	0.0%	N/A	0.109%
11/12/2024	Charles Schwab Investment Management Inc.	1,184,609	$27.71M	0.0%	+0.7%	0.765%
11/9/2024	Intech Investment Management LLC	48,263	$1.13M	0.0%	N/A	0.031%
11/8/2024	Segall Bryant & Hamill LLC	52,390	$1.23M	0.0%	N/A	0.034%
11/8/2024	Prospera Financial Services Inc	35,713	$0.84M	0.0%	-7.1%	0.023%
11/7/2024	Quest Partners LLC	10,529	$0.25M	0.0%	N/A	0.007%
11/7/2024	Swiss National Bank	286,600	$6.70M	0.0%	-0.7%	0.185%
11/7/2024	Thrivent Financial for Lutherans	104,764	$2.45M	0.0%	N/A	0.068%
11/6/2024	Mutual of America Capital Management LLC	20,064	$0.47M	0.0%	N/A	0.013%
11/6/2024	Empowered Funds LLC	46,431	$1.09M	0.0%	+3.1%	0.030%
11/6/2024	KBC Group NV	4,675	$0.11M	0.0%	+30.5%	0.003%
11/6/2024	Oppenheimer & Co. Inc.	32,470	$0.76M	0.0%	N/A	0.021%
11/5/2024	Victory Capital Management Inc.	32,679	$0.76M	0.0%	+24.7%	0.021%
11/5/2024	GSA Capital Partners LLP	10,987	$0.26M	0.0%	-55.1%	0.007%
11/5/2024	Entropy Technologies LP	31,200	$0.73M	0.1%	N/A	0.020%
11/4/2024	Los Angeles Capital Management LLC	123,401	$2.89M	0.0%	+33.7%	0.080%
11/4/2024	State of New Jersey Common Pension Fund D	82,752	$1.94M	0.0%	-27.2%	0.053%
10/31/2024	Principal Financial Group Inc.	772,188	$18.06M	0.0%	+1,549.4%	0.500%
10/30/2024	Amalgamated Bank	39,528	$0.93M	0.0%	+712.0%	0.026%
10/25/2024	Iridian Asset Management LLC CT	47,532	$1.11M	0.2%	+20.8%	0.031%
10/25/2024	New York State Teachers Retirement System	42,927	$1M	0.0%	N/A	0.028%
10/24/2024	State of Alaska Department of Revenue	76,130	$1.78M	0.0%	N/A	0.049%
10/23/2024	Louisiana State Employees Retirement System	64,500	$1.51M	0.0%	N/A	0.042%
10/23/2024	CWC Advisors LLC.	16,150	$0.38M	0.4%	N/A	0.010%
10/23/2024	Values First Advisors Inc.	2,496	$58K	0.0%	N/A	0.002%
10/23/2024	Assenagon Asset Management S.A.	170,234	$3.98M	0.0%	-65.2%	0.110%
10/23/2024	Hennion & Walsh Asset Management Inc.	98,629	$2.31M	0.1%	-2.7%	0.064%
10/22/2024	Private Advisor Group LLC	14,407	$0.34M	0.0%	+3.9%	0.009%
10/21/2024	Everence Capital Management Inc.	16,260	$0.38M	0.0%	N/A	0.011%
10/21/2024	Wealth Effects LLC	14,500	$0.34M	0.1%	-12.1%	0.009%
10/19/2024	Allspring Global Investments Holdings LLC	17,118	$0.40M	0.0%	-6.5%	0.011%
10/18/2024	Raymond James & Associates	170,160	$3.98M	0.0%	+35.9%	0.110%
10/18/2024	Blue Trust Inc.	1,516	$35K	0.0%	+127.3%	0.001%
10/16/2024	Avaii Wealth Management LLC	28,984	$0.68M	0.3%	-4.1%	0.019%
10/16/2024	Vontobel Holding Ltd.	9,500	$0.22M	0.0%	N/A	0.006%
10/15/2024	NBC Securities Inc.	1,309	$30K	0.0%	+58.9%	0.001%
10/11/2024	Creative Planning	55,832	$1.31M	0.0%	+19.2%	0.036%
10/11/2024	ORG Wealth Partners LLC	2,252	$53K	0.0%	N/A	0.001%
10/10/2024	Valeo Financial Advisors LLC	10,223	$0.24M	0.0%	N/A	0.007%
10/8/2024	Daymark Wealth Partners LLC	40,811	$0.96M	0.0%	+73.7%	0.026%
10/5/2024	Handelsbanken Fonder AB	49,900	$1.17M	0.0%	+22.6%	0.032%
10/3/2024	SG Americas Securities LLC	23,614	$0.55M	0.0%	+181.9%	0.015%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	10,166	$0.18M	0.0%	-57.2%	0.007%
9/11/2024	Newbridge Financial Services Group Inc.	3,084	$55K	0.0%	-15.8%	0.002%
8/22/2024	Cetera Investment Advisers	53,425	$0.95M	0.0%	-15.3%	0.035%
8/19/2024	Point72 Asset Management L.P.	585,873	$10.42M	0.0%	N/A	0.379%
8/16/2024	Quarry LP	6,003	$0.11M	0.0%	+9.1%	0.004%
8/16/2024	Creative Planning	46,839	$0.83M	0.0%	+34.7%	0.030%
8/16/2024	Algert Global LLC	147,218	$2.62M	0.1%	+193.8%	0.095%
8/15/2024	Lighthouse Investment Partners LLC	111,092	$1.98M	0.1%	N/A	0.072%
8/15/2024	The Manufacturers Life Insurance Company	80,664	$1.44M	0.0%	+3.7%	0.052%
8/15/2024	Millennium Management LLC	1,457,908	$25.94M	0.0%	-57.4%	0.943%
8/15/2024	Dark Forest Capital Management LP	41,252	$0.73M	0.1%	N/A	0.027%
8/15/2024	AQR Capital Management LLC	38,025	$0.68M	0.0%	-14.3%	0.025%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	10,166	$0.18M	0.0%	-57.2%	0.007%
8/15/2024	Point72 Europe London LLP	160,769	$2.86M	0.2%	N/A	0.104%
8/14/2024	Squarepoint Ops LLC	51,711	$0.92M	0.0%	-15.6%	0.033%
8/14/2024	Marshall Wace LLP	2,051,762	$36.50M	0.0%	N/A	1.328%
8/14/2024	Magnetar Financial LLC	36,753	$0.65M	0.0%	-29.5%	0.024%
8/14/2024	Hood River Capital Management LLC	1,572,929	$27.98M	0.6%	+6.7%	1.018%
8/14/2024	ProShare Advisors LLC	18,575	$0.33M	0.0%	-25.4%	0.012%
8/14/2024	Profund Advisors LLC	62,616	$1.11M	0.0%	-27.0%	0.041%
8/13/2024	Sei Investments Co.	37,557	$0.67M	0.0%	-3.3%	0.024%
8/13/2024	Canada Pension Plan Investment Board	1,500	$27K	0.0%	-96.7%	0.001%
8/12/2024	XTX Topco Ltd	22,176	$0.40M	0.0%	N/A	0.014%
8/12/2024	E Fund Management Co. Ltd.	20,465	$0.36M	0.0%	-20.8%	0.013%
8/10/2024	Sofinnova Investments Inc.	1,861,277	$33.11M	1.7%	-6.2%	1.204%
8/9/2024	Renaissance Technologies LLC	309,371	$5.50M	0.0%	-63.2%	0.200%
8/8/2024	J.W. Cole Advisors Inc.	15,700	$0.28M	0.0%	-18.9%	0.010%
8/8/2024	State of New Jersey Common Pension Fund D	113,683	$2.02M	0.0%	N/A	0.074%
8/7/2024	Headlands Technologies LLC	6,980	$0.12M	0.0%	N/A	0.005%
8/7/2024	Ashton Thomas Private Wealth LLC	1,986	$35K	0.0%	N/A	0.001%
8/6/2024	Strategic Financial Concepts LLC	29,776	$0.53M	0.0%	N/A	0.019%
8/6/2024	Los Angeles Capital Management LLC	92,277	$1.64M	0.0%	+20.4%	0.060%
8/5/2024	Arizona State Retirement System	41,069	$0.73M	0.0%	+3.9%	0.027%
8/5/2024	Victory Capital Management Inc.	26,212	$0.47M	0.0%	+24.6%	0.017%
8/1/2024	Rhumbline Advisers	215,055	$3.83M	0.0%	+7.8%	0.139%
7/31/2024	nVerses Capital LLC	5,800	$0.10M	0.1%	+34.9%	0.004%
7/31/2024	Commonwealth Equity Services LLC	186,994	$3.33M	0.0%	+1.3%	0.121%
7/29/2024	Principal Financial Group Inc.	46,817	$0.83M	0.0%	+32.3%	0.030%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	27,800	$0.50M	0.0%	-2.2%	0.018%
7/29/2024	Burney Co.	44,998	$0.80M	0.0%	N/A	0.029%
7/26/2024	Iridian Asset Management LLC CT	39,357	$0.70M	0.2%	N/A	0.025%
7/26/2024	Allspring Global Investments Holdings LLC	18,313	$0.33M	0.0%	+1,080.0%	0.012%
7/26/2024	Bank of New York Mellon Corp	503,645	$8.96M	0.0%	+13.4%	0.326%
7/25/2024	Clear Creek Financial Management LLC	18,850	$0.34M	0.0%	-5.0%	0.012%
7/20/2024	Hennion & Walsh Asset Management Inc.	101,369	$1.80M	0.1%	-45.2%	0.066%

Data available starting January 2016

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.

Today's Range

Now: $30.84

$30.36

$36.50

50 Day Range

MA: $24.41

$21.31

$34.90

52 Week Range

Now: $30.84

$10.82

$36.50

Volume

8,135,424 shs

Average Volume

3,710,438 shs

Market Capitalization

$4.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.19

Who are the company insiders with the largest holdings of TG Therapeutics?: TG Therapeutics' top insider investors include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Laurence N Charney (Director)
Yann Echelard (Director)
Sagar Lonial (Director)
Learn More about top insider investors at TG Therapeutics.
Who are the major institutional investors of TG Therapeutics?: TG Therapeutics' top institutional shareholders include:
Charles Schwab Investment Management Inc. — 0.77%
FMR LLC — 0.76%
Principal Financial Group Inc. — 0.50%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.19%
Swiss National Bank — 0.19%
Public Sector Pension Investment Board — 0.18%
Learn More about top institutional investors of TG Therapeutics stock.
Which institutional investors are selling TG Therapeutics stock?: In the previous quarter, TGTX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Walleye Capital LLC
Algert Global LLC
FMR LLC
State of New Jersey Common Pension Fund D
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
BNP Paribas Financial Markets
GSA Capital Partners LLP
In the previous year, company insiders that have sold TG Therapeutics company stock include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Laurence N Charney (Director)
Learn More investors selling TG Therapeutics stock.
Which institutional investors are buying TG Therapeutics stock?: In the last quarter, TGTX stock was bought by institutional investors including:
Principal Financial Group Inc.
Public Sector Pension Investment Board
Eagle Asset Management Inc.
Thrivent Financial for Lutherans
Citigroup Inc.
State of Alaska Department of Revenue
Penserra Capital Management LLC
Louisiana State Employees Retirement System
Within the previous year, these company insiders have bought TG Therapeutics stock:
Michael S Weiss (CEO)
Sean A Power (CFO)
Learn More investors buying TG Therapeutics stock.